Underutilization of prophylaxis for osteoporosis

Archives of Dermatology

Volumn 146, Issue 10, 2010, Pages 1131-

  Stratman, Erik J ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

AUTOIMMUNE SKIN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; HEALTH CARE; HUMAN; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SHORT SURVEY; STEROID THERAPY; COMPLICATION; PEMPHIGUS; PHOTON ABSORPTIOMETRY; UTILIZATION;

ABSORPTIOMETRY, PHOTON; HUMANS; OSTEOPOROSIS; PEMPHIGUS;

EID: 77958156784     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.250     Document Type: Short Survey

References (2)

1. Buckley LM, Marquez M, Hudson JO, et al. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty. J Rheumatol. 1998;25(11):2195-2202. (Pubitemid 28505868)
2. Summey BT, Yosipovitch G. Glucocorticoid-induced bone loss in dermatologic patients: an update. Arch Dermatol. 2006;142(1):82-90.